Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia

Frida Danielsson, Erik Fasterius, Devin P. Sullivan, Linnea Hases, Kemal Sanli, Cheng Zhang, Adil Mardinoğlu, Cristina Al‐Khalili Szigyarto, Mikael Huss, Mathias Uhlén, Cecilia Williams, Emma LundbergOncotarget 2018 · DOI

TL;DR

This study uses a sophisticated isogenic cell model to reveal how cancer cells adapt to low oxygen (hypoxia) and how this adaptation mirrors the process of malignant transformation. They found that a specific gene, ASS1, shows a distinct expression pattern in response to hypoxia in malignant cells, suggesting it could be a new marker for predicting poor prognosis in hypoxic tumors.

What Problem Does This Paper Address?

Cancer cells often outgrow their blood supply, leading to low oxygen environments within tumors (hypoxia). This hypoxia is a known driver of tumor progression and resistance to treatment. Understanding how cells respond to hypoxia and how this response intersects with the fundamental changes that lead to cancer (malignant transformation) is crucial for developing better therapies. While many studies look at either cancer progression or hypoxic response individually, this paper aims to bridge these two areas by investigating how the cellular response to hypoxia changes as cells become progressively more malignant. They use a unique four-step isogenic BJ cell model, which allows for the study of defined stages of tumorigenesis under controlled conditions, making it ideal for dissecting these complex interactions.

Methods

The core of this study relies on RNA sequencing (RNA-seq) to profile the transcriptome (the complete set of RNA transcripts) of four isogenic BJ cell lines. These cell lines represent distinct stages of tumorigenesis: normal, immortalized, transformed, and metastasizing. The researchers cultured these cell lines under two conditions: standard atmospheric oxygen and moderate hypoxia (3% O₂). After six passages, they extracted RNA and performed RNA-seq.

Key analytical steps included:

  • Differential Gene Expression Analysis: Identifying genes whose expression levels changed significantly between oxygen conditions (hypoxia-induced DEGs or hDEGs) and between different stages of malignancy under atmospheric conditions.
  • Functional Enrichment Analysis: Using tools like DAVID to identify biological pathways and functions that were overrepresented among the differentially expressed genes. This helps understand the biological impact of hypoxia and transformation.
  • Network Analysis: Employing tools like EnrichmentMap to visualize and analyze relationships between genes and pathways.
  • Immunofluorescence Staining: Visualizing the protein levels of Hypoxia-Inducible Factor 1-alpha (HIF1α) to confirm its role in hypoxic response.
  • Metabolic Profiling: Using the KEGG Orthology database and the PACFM tool to analyze how metabolic pathways were affected by hypoxia across different cell stages.
  • Survival Analysis: Utilizing clinical data from The Cancer Genome Atlas (TCGA) to assess the prognostic value of identified genes.

Datasets

The primary dataset used in this study is the transcriptomic data generated from the four-step isogenic BJ cell model under atmospheric and hypoxic conditions. This dataset was deposited in NCBI's Gene Expression Omnibus (GEO) with accession number GSE109367.

Additionally, clinical data from The Cancer Genome Atlas (TCGA) was used for survival analysis of the ASS1 gene. Specifically, an endometrial cancer patient cohort was analyzed.

Key Insights and Ideas

  • Hypoxia Mimics Malignant Transformation: A major finding is that the cellular response to moderate hypoxia (changes in gene expression) significantly overlaps with the changes observed during malignant transformation in this model. This suggests that the cellular machinery responding to low oxygen might share pathways with those driving cancer development.
  • SV40 Transformation is a Key Divergence Point: The introduction of the SV40 Large-T oncogene appears to be a critical step that dramatically alters the cellular response to hypoxia. This stage, and the subsequent metastasizing stage, show a distinct pattern of gene regulation compared to the earlier, pre-malignant stages.
  • Metabolic Rewiring is Crucial: Hypoxia triggers significant changes in metabolic pathways, particularly in the transformed and metastasizing cells. This includes an upregulation of biosynthetic pathways and a shift away from oxidative phosphorylation, consistent with the Warburg effect observed in many cancers.
  • ASS1 as a Potential Prognostic Marker: The gene ASS1 (Argininosuccinate synthase) exhibits a striking difference in its response to hypoxia between pre-malignant and malignant cells. It is downregulated in pre-malignant cells but upregulated in malignant cells. This differential regulation, coupled with TCGA data showing worse survival in patients with high ASS1 expression, positions ASS1 as a promising marker for poor prognosis in hypoxic tumors.

Key Results

  • Differential Gene Expression: The study identified thousands of hypoxia-induced differentially expressed genes (hDEGs) across the four cell stages, with the transformed stage showing the most pronounced response.
  • Pathway Enrichment: Functional enrichment analysis revealed that genes related to proliferation, angiogenesis, apoptosis, migration, and metabolic processes were significantly affected by hypoxia.
  • HIF1α Regulation: While HIF1α protein levels increased with hypoxia in primary cells, later-stage cells showed elevated basal HIF1α levels even under atmospheric conditions, suggesting a modified hypoxic response post-transformation.
  • Metabolic Shifts: The SV40-transformed stage showed a significant upregulation of metabolic genes, indicating a metabolic switch. Genes involved in lipid, carbohydrate, and amino acid metabolism were particularly affected.
  • ASS1 Prognostic Value: Survival analysis of TCGA data demonstrated that high ASS1 expression in endometrial cancer patients was significantly associated with worse survival over a ten-year period (p = 8.14 × 10⁻⁹).

Limitations and Future Work

  • In Vitro vs. In Vivo: The authors acknowledge that cell lines are simplifications of complex in vivo tumor environments. Interactions with other cell types and the extracellular matrix are not fully captured.
  • Atmospheric Oxygen Origin: The initial creation of the BJ model under atmospheric oxygen pressure is noted as a potential limitation.
  • Protein Level Validation: While RNA-seq provides transcriptomic data, the authors suggest that follow-up studies should validate these findings at the protein level, especially under hypoxic conditions, as protein levels can be influenced by post-transcriptional regulation.
  • Clinical Data Limitations: The authors note that their ASS1 prognostic findings are based on endometrial cancer data and that the TCGA data used lacked specific information on tumor hypoxia, which they speculate could further strengthen the link.

Future work could involve exploring the protein-level changes of key genes like ASS1 and HIF1α in hypoxic tumors, investigating the precise mechanisms by which SV40 transformation alters hypoxic response, and further validating ASS1 as a prognostic marker in diverse hypoxic cancer types. The study also highlights the potential of this isogenic model for discovering other novel prognostic markers by exposing it to various perturbations.

Summary updated

Abstract

In tumor tissues, hypoxia is a commonly observed feature resulting from rapidly proliferating cancer cells outgrowing their surrounding vasculature network. Transformed cancer cells are known to exhibit phenotypic alterations, enabling continuous proliferation despite a limited oxygen supply. The four-step isogenic BJ cell model enables studies of defined steps of tumorigenesis: the normal, immortalized, transformed, and metastasizing stages. By transcriptome profiling under atmospheric and moderate hypoxic (3% O<sub>2</sub>) conditions, we observed that despite being highly similar, the four cell lines of the BJ model responded strikingly different to hypoxia. Besides corroborating many of the known responses to hypoxia, we demonstrate that the transcriptome adaptation to moderate hypoxia resembles the process of malignant transformation. The transformed cells displayed a distinct capability of metabolic switching, reflected in reversed gene expression patterns for several genes involved in oxidative phosphorylation and glycolytic pathways. By profiling the stage-specific responses to hypoxia, we identified ASS1 as a potential prognostic marker in hypoxic tumors. This study demonstrates the usefulness of the BJ cell model for highlighting the interconnection of pathways involved in malignant transformation and hypoxic response.
BibTeX
@inproceedings{danielsson2018transcriptome,
  author = {Frida Danielsson and Erik Fasterius and Devin P. Sullivan and Linnea Hases and Kemal Sanli and Cheng Zhang and Adil Mardinoğlu and Cristina Al‐Khalili Szigyarto and Mikael Huss and Mathias Uhlén and Cecilia Williams and Emma Lundberg},
  title = {{Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia}},
  booktitle = {Oncotarget},
  year = {2018},
  doi = {10.18632/oncotarget.24808},
}
Figure